The Trump administration’s latest effort to lower drug costs is expanding to biosimilars, medications that are highly similar to biologic drugs made with or isolated from living organisms such as ...

Expecting Growth in 2026 Families are not just receiving results - they are gaining the confidence and capability to ...

The longevity industry has reached an inflection point. With companies like Function Health raising hundreds of millions in ...

A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in ...

As medicine advances toward more individualized care, clinical diagnostics are playing an increasingly vital role. Traditionally, diagnostic tests have been used to identify and classify diseases.

As we start a new year, the clinical diagnostics industry finds itself at the intersection of rapid technological progress and significant uncertainty. I anticipate that continued innovation amid this ...

Upheaval during the COVID pandemic has forced a rethinking of the steps to medical licensure, most recently clinical skills assessments. As a result, medical students across the nation will likely ...

Neuropsychiatric disorders need new drugs that offer improvement in safety and efficacy over currently available medicines. Draig Therapeutics has emerged from stealth with $140 million to support mid ...

Trial Evaluates Solution to Sample Tampering in Point-of-Care Urine Drug Testing The EvoClinical team is proud to ...

A protein lurking around in the blood can help with the accurate diagnosis of Alzheimer's disease. In a recent study, ...

Kymera Therapeutics has announced that Sanofi will advance their next-generation oral IRAK4 degrader, KT-485, into clinical testing, while opting not to pursue KT-474. Preclinical studies indicated ...